← Eichor
Condition: Opioid Abuse Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Opioid Abuse Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment
NA · 1 location(s) · Emory University · NCT05711056Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prev
NA · 1 location(s) · Chestnut Health Systems · NCT06852170Cannabis Use and Outcomes in Black and White Patients With Cancer
Phase N/A · 3 location(s) · State University of New York at Buffalo · NCT06037681Opioid/Benzodiazepine Polydrug Abuse: Aim 3
Phase 2 · 1 location(s) · Wayne State University · NCT05006079Nalmefene Implant in Healthy Subjects
Phase 1 · 1 location(s) · ReacX Pharmaceuticals, Inc. · NCT07325279CEDRN: Opioid Registry
Phase N/A · 1 location(s) · University of British Columbia · NCT07466784Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)
NA · 4 location(s) · InSightec · NCT04197921Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
NA · 2 location(s) · Wake Forest University Health Sciences · NCT04927143Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy
Phase 2 · 1 location(s) · BC Centre on Substance Use · NCT05985850Focused Ultrasound for the Complex Patient
NA · 1 location(s) · Washington D.C. Veterans Affairs Medical Center · NCT06453109Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Phase N/A · 1 location(s) · Yale University · NCT01730781GLP-1R Agonist Treatment for Opioid Use Disorder
Phase 2 · 4 location(s) · Milton S. Hershey Medical Center · NCT06548490Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
NA · 1 location(s) · Baylor College of Medicine · NCT05489042Cannabis and Opioid Use Disorder
Phase 1 · 1 location(s) · Shanna Babalonis, PhD · NCT05729932Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
Phase 4 · 1 location(s) · Vanderbilt University Medical Center · NCT05988710A Unique, Co-Designed Family-Based Therapy
NA · 1 location(s) · Ohio State University · NCT07587359Opioid Drug Interaction Study
Phase 1/Phase 2 · 1 location(s) · Shanna Babalonis, PhD · NCT06757140Optimizing Pregnancy and Treatment Interventions for Moms 3.0
NA · 1 location(s) · University of Utah · NCT07586917Opioid/Benzodiazepine Polydrug Abuse
Phase N/A · 1 location(s) · Wayne State University · NCT03696017Harm Reduction Services
NA · 3 location(s) · NYU Langone Health · NCT05776316fMRI and Opioid Abstinence
Phase N/A · 1 location(s) · Yale University · NCT06651333The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Dis
NA · 1 location(s) · Oregon Health and Science University · NCT06837662
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.